Report Detail
Global Chickenpox Vaccine Market Insights, Forecast to 2025
- RnM3412442 |
- 13 May, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Chickenpox vaccine, also known as varicella vaccine, is a vaccine that protects against chickenpox.One dose of this vaccine prevents 100% of severe disease and 95% of moderate disease. Varicella vaccine is made up of Oka strain of live attenuated virus. This vaccine is safe and constitutes rare severe side effects. Moreover, varicella vaccine is 7090% effective in preventing varicella. We mainly focus on live attenuated varicella vaccine in this report.
The global Chickenpox Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Chickenpox Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Chickenpox Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Chickenpox Vaccine in these regions.
This research report categorizes the global Chickenpox Vaccine market by top players/brands, region, type and end user. This report also studies the global Chickenpox Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Market size by Product
Monovalent Vaccine
Combination Vaccine
Market size by End User
Kids Injection
Adults Injection
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Chickenpox Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Chickenpox Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Chickenpox Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Chickenpox Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Chickenpox Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Chickenpox Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Chickenpox Vaccine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Chickenpox Vaccine Market Size Growth Rate by Product
- 1.4.2 Monovalent Vaccine
- 1.4.3 Combination Vaccine
- 1.5 Market by End User
- 1.5.1 Global Chickenpox Vaccine Market Size Growth Rate by End User
- 1.5.2 Kids Injection
- 1.5.3 Adults Injection
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Chickenpox Vaccine Market Size
- 2.1.1 Global Chickenpox Vaccine Revenue 2014-2025
- 2.1.2 Global Chickenpox Vaccine Sales 2014-2025
- 2.2 Chickenpox Vaccine Growth Rate by Regions
- 2.2.1 Global Chickenpox Vaccine Sales by Regions
- 2.2.2 Global Chickenpox Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Chickenpox Vaccine Sales by Manufacturers
- 3.1.1 Chickenpox Vaccine Sales by Manufacturers
- 3.1.2 Chickenpox Vaccine Sales Market Share by Manufacturers
- 3.1.3 Global Chickenpox Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.2 Chickenpox Vaccine Revenue by Manufacturers
- 3.2.1 Chickenpox Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Chickenpox Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.3 Chickenpox Vaccine Price by Manufacturers
- 3.4 Chickenpox Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Chickenpox Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Chickenpox Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Chickenpox Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Chickenpox Vaccine Sales by Product
- 4.2 Global Chickenpox Vaccine Revenue by Product
- 4.3 Chickenpox Vaccine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Chickenpox Vaccine Breakdown Data by End User
6 North America
- 6.1 North America Chickenpox Vaccine by Countries
- 6.1.1 North America Chickenpox Vaccine Sales by Countries
- 6.1.2 North America Chickenpox Vaccine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Chickenpox Vaccine by Product
- 6.3 North America Chickenpox Vaccine by End User
7 Europe
- 7.1 Europe Chickenpox Vaccine by Countries
- 7.1.1 Europe Chickenpox Vaccine Sales by Countries
- 7.1.2 Europe Chickenpox Vaccine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Chickenpox Vaccine by Product
- 7.3 Europe Chickenpox Vaccine by End User
8 Asia Pacific
- 8.1 Asia Pacific Chickenpox Vaccine by Countries
- 8.1.1 Asia Pacific Chickenpox Vaccine Sales by Countries
- 8.1.2 Asia Pacific Chickenpox Vaccine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Chickenpox Vaccine by Product
- 8.3 Asia Pacific Chickenpox Vaccine by End User
9 Central & South America
- 9.1 Central & South America Chickenpox Vaccine by Countries
- 9.1.1 Central & South America Chickenpox Vaccine Sales by Countries
- 9.1.2 Central & South America Chickenpox Vaccine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Chickenpox Vaccine by Product
- 9.3 Central & South America Chickenpox Vaccine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Chickenpox Vaccine by Countries
- 10.1.1 Middle East and Africa Chickenpox Vaccine Sales by Countries
- 10.1.2 Middle East and Africa Chickenpox Vaccine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Chickenpox Vaccine by Product
- 10.3 Middle East and Africa Chickenpox Vaccine by End User
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Merck Chickenpox Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Merck Chickenpox Vaccine Products Offered
- 11.1.5 Merck Recent Development
- 11.2 GSK
- 11.2.1 GSK Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GSK Chickenpox Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GSK Chickenpox Vaccine Products Offered
- 11.2.5 GSK Recent Development
- 11.3 Shanghai Institute
- 11.3.1 Shanghai Institute Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Shanghai Institute Chickenpox Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Shanghai Institute Chickenpox Vaccine Products Offered
- 11.3.5 Shanghai Institute Recent Development
- 11.4 BCHT
- 11.4.1 BCHT Company Details
- 11.4.2 Company Business Overview
- 11.4.3 BCHT Chickenpox Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 BCHT Chickenpox Vaccine Products Offered
- 11.4.5 BCHT Recent Development
- 11.5 Changsheng
- 11.5.1 Changsheng Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Changsheng Chickenpox Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Changsheng Chickenpox Vaccine Products Offered
- 11.5.5 Changsheng Recent Development
- 11.6 Keygen
- 11.6.1 Keygen Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Keygen Chickenpox Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Keygen Chickenpox Vaccine Products Offered
- 11.6.5 Keygen Recent Development
- 11.7 Green Cross
- 11.7.1 Green Cross Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Green Cross Chickenpox Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Green Cross Chickenpox Vaccine Products Offered
- 11.7.5 Green Cross Recent Development
- 11.8 Biken
- 11.8.1 Biken Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Biken Chickenpox Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Biken Chickenpox Vaccine Products Offered
- 11.8.5 Biken Recent Development
12 Future Forecast
- 12.1 Chickenpox Vaccine Market Forecast by Regions
- 12.1.1 Global Chickenpox Vaccine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Chickenpox Vaccine Revenue Forecast by Regions 2019-2025
- 12.2 Chickenpox Vaccine Market Forecast by Product
- 12.2.1 Global Chickenpox Vaccine Sales Forecast by Product 2019-2025
- 12.2.2 Global Chickenpox Vaccine Revenue Forecast by Product 2019-2025
- 12.3 Chickenpox Vaccine Market Forecast by End User
- 12.4 North America Chickenpox Vaccine Forecast
- 12.5 Europe Chickenpox Vaccine Forecast
- 12.6 Asia Pacific Chickenpox Vaccine Forecast
- 12.7 Central & South America Chickenpox Vaccine Forecast
- 12.8 Middle East and Africa Chickenpox Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Chickenpox Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Chickenpox Vaccine . Industry analysis & Market Report on Chickenpox Vaccine is a syndicated market report, published as Global Chickenpox Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Chickenpox Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
